Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12623001116617
ACTRN12623001116617
Suspended
未知

utromics Biosensor Characterisation (NBC) Study to measure endogenous analytes in the interstitial space with a novel, minimally invasive biosensor in healthy participants.

utromics Operations0 sites50 target enrollmentOctober 26, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGlucose monitoringPhenylalanine MonitoringCreatinine MonitoringMetabolic and Endocrine - DiabetesHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersRenal and Urogenital - Kidney disease

Overview

Phase
未知
Intervention
Not specified
Conditions
Glucose monitoring
Sponsor
utromics Operations
Enrollment
50
Status
Suspended
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
utromics Operations

Eligibility Criteria

Inclusion Criteria

  • •Participants self\-declaring healthy without any disease, condition or syndrome or on any current medical treatment.
  • •Aged 18 and above

Exclusion Criteria

  • •Participants who have declared they are pregnant.
  • •Participants who declare previous allergic reactions to metals, plastics, and adhesives

Outcomes

Primary Outcomes

Not specified

Similar Trials

Suspended
Not Applicable
A study exploring new biomarkers by measuring the rest-activity rhythms of patients with schizophrenia and mood disordersSchizophrenia and mood disorders
JPRN-UMIN000045175Fujita Health University90
Not yet recruiting
Not Applicable
The evaluation of a novel biosensor to continuously monitor human fetal scalp lactate intrapartum
ACTRN12624000925549VitalTrace Pty Ltd20
Completed
Not Applicable
Observational study on the detection of biomarkers of diseases of the respiratory system by means of ion mobility spectrometry.J98.8U07.1Other specified respiratory disordersCOVID-19, virus identified
DRKS00025842Immanuel Klinikum Bernau Herzzentrum Brandenburg Hochschulklinikum der Medizinischen Hochschule Brandenburg137
Completed
Not Applicable
Efficacy of a wearable biosensor for patients with COVID-19 or cardiopulmonary diseasesi) SARS-CoV-2 PCR positive COVID-19 patient ii) Heart failure iii) Sleep apnea syndrome iv) Asthma v) Chronic obstructive pulmonary disease vi) Intestinal pneumonia vii) Pulmonary mycobacterium avium complex disease viii) Pediatric inguinal hernia ix) Congenital cystic disease of lung x) Pediatric metastatic lung tumors xi) Pneumonia
JPRN-UMIN000043546Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan20
Recruiting
Not Applicable
An observational study to determine biomarkers for prognosis of lung lesions in patients with polymyositis/dermatomyositis complicated by interstitial lung diseasePolymyositis/dermatomyositis complicated with interstitial lung disease (PM/DM-ILD)
JPRN-UMIN000046198agasaki University125